Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder

Psychotherapy and Psychosomatics

Volumn 77, Issue 6, 2008, Pages 393-394

  Nakatani, Eriko ^a   Nakagawa, Akiko ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE;

ADULT; BEHAVIOR THERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG DOSE REDUCTION; HUMAN; LETTER; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADULT; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; FEMALE; FLUVOXAMINE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 49849085819     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151521     Document Type: Letter

References (5)

1. Nakatani E, Nakagawa A, Nakao T, Yoshizato C, Nabeyama M, Kudo A, Isomura K, Kato N, Yoshioka K, Kawamoto M: A randomized controlled trial of Japanese patients with obsessive-compulsive disorder - Effectiveness of behavior therapy and fluvoxamine. Psychother Psychosom 2005;74:269-276.
2. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R - Patient Edition (SCID-P). Washington, American Psychiatric Press, 1990.
3. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale. 1. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011.
4. Guy W: ECDEU Assessment Manual for Psychopharmacology. Washington, US Department of Health, Education and Welfare, 1967.
5. Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P: Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 2004;65:922-931.